Watch: Natco partner's multiple sclerosis injection gets USFDA nod
The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate injection used for treatment of relapsing forms of multiple sclerosis (MS).
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
